More media releases
More from the studio
International radiopharmaceutical company Clarity has licensed technology developed at the University of Melbourne for imaging and treating prostate cancer.
Researchers have identified some common genetic cancer mutations could indicate the presence of much more influential rare “hidden” mutations that could lead to earlier detection of prostate cancer.
General media enquiries:
+61 3 8344 4123
The Media Office is staffed from8am - 5pm Monday to Friday.
About us »
Subscribe to the latest news from the university
Human rights and international law expert Professor Hilary Charlesworth, says that Australia's appointment to the UN Human Rights Council gives the country an opportunity to examine its own human rights record.